- Advertisement -spot_img
Thursday, April 15, 2021

The US State Department raised these questions again in the US and WHO.

Must read

Washington DC: The US rejected the World Health Organization (WHO) report on the origin of Kovid-19, saying it lacked critical data and information. The US also urged the WHO to ensure Phase 2 of the study without delay in order to follow the principles of transparency and free it from political interference.

A US State Department spokesman said, “It is clear from our review of the report that it lacks critical data, information, access and represents a picture that is incomplete. It is not just our view.” ‘

Ned Price said, “We urge the WHO to ensure that the second phase of this study begins without delay, including in China, in a way that respects and adheres to the principles of transparency and openness.” Operated by experts and free from political interference. “

Price said the WHO should evaluate how the virus started so that important lessons on the virus can be learned. He said, “We also ask WHO to reevaluate the criteria and conditions of this process. We need to understand (I am collectively using ‘we’ here) how and where this virus Started so that we can learn a lesson. ”

US begins study of allergic reactions to COVID-19 vaccine
Meanwhile, the US National Institutes of Health (NIH) has initiated a study to determine the risk of allergy to Pfizer-BioNotech and Modern Kovid-19 vaccines.

“The public is concerned about reports of rare, severe allergic reactions to the modern and Pfizer-BioNotech COVID-19 vaccine,” said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID).

He stated, “The information collected during this test will advise those who are highly allergic or have a mast cell disorder about the risks and benefits of receiving these two vaccines. However, COVID-19 vaccination for most people The benefits of have outweighed the risks. “

.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news